Bone Marrow Characteristics Associated with Changes in Infarct Size after STEMI: A Biorepository Evaluation from the CCTRN TIME Trial

RATIONALE: Despite significant interest in bone marrow mononuclear cell (BMC) therapy for ischemic heart disease, current techniques have resulted in only modest benefits. However, select patients have shown improvements after autologous BMC therapy, but the contributing factors are unclear. OBJECTI...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circ Res
Autors principals: Schutt, Robert C., Trachtenberg, Barry H., Cooke, John P., Traverse, Jay H., Henry, Timothy D., Pepine, Carl J., Willerson, James T., Perin, Emerson C., Ellis, Stephen G., Zhao, David X. M., Bhatnagar, Aruni, Johnstone, Brian H., Lai, Dejian, Resende, Micheline, Ebert, Ray F., Wu, Joseph C., Sayre, Shelly L., Orozco, Aaron, Zierold, Claudia, Simari, Robert D., Moyé, Lem, Cogle, Christopher R., Taylor, Doris A.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282599/
https://ncbi.nlm.nih.gov/pubmed/25406300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.116.304710
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars